Investigation into improving quality of life after cancer

June 27, 2006

Researchers at the University of Liverpool have been awarded £1.9 million to further understanding of how the quality of patients' lives can be improved following serious illness. The 'Cancer Experiences Collaborative' will investigate ways in which patients and their families can cope more effectively and maximise the benefits of treatment. Researchers also aim to improve the understanding of the social, psychological and clinical problems experienced by elderly people and people with cancer.

Professor Mari Lloyd-Williams leads Liverpool's Academic Palliative and Supportive Care Studies Group, said: "The experiences of people affected by cancer can help further understanding of the disease so that improvements in facilities, clinical environments and supportive care can be specifically targeted.

"As well as carrying out new programmes of research, we will be supporting and mentoring individuals to enable them to become independent researchers in palliative and supportive care."

The University of Liverpool is already an international centre of excellence for palliative and supportive care research. Academics will focus on how to manage specific symptoms such as depression, nausea, fatigue and breathlessness associated with cancer and other end-stage illnesses in order to allow the greatest quality of life.

Together with the Universities of Lancaster, Manchester, Sheffield and Southampton the University of Liverpool will also be working with leading hospice charities, cancer clinicians and service providers. The research, funded by the National Cancer Research Institute, also aims to improve clinical practice and the way palliative and supportive care services are organised.
-end-
Notes to editors

1. The University of Liverpool is one of the UK's leading research institutions. It attracts collaborative and contract research commissions from a wide range of national and international organisations valued at more than £90 million annually.

University of Liverpool

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.